Sublingual Nitroglycerin Practices In Patients With Coronary Artery Disease In Australia

Lippincott Williams & Wilkins
Publication Type:
Journal Article
Journal of Cardiovascular Nursing, 2010, 25 (6), pp. 480 - 486
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010002538OK.pdf190.07 kB
Adobe PDF
Background and Research Objective: Sublingual nitroglycerin (SLNTG) medications are a recommended treatment for people with coronary artery disease (CAD); however, prescription and knowledge may be suboptimal.
Please use this identifier to cite or link to this item: